2020 Elections, the Supreme Court, and the Future of Health Care
On October 8, Brownstein’s Health Care industry group hosted a panel discussion with industry experts about what the election, the Affordable Care Act challenge before the Supreme Court and policy trends mean for the future of health care and industry transactions. The discussion includes a pre-election assessment on further COVID aid legislation, the likely result of the ACA challenge, potential Trump and Biden presidential priorities on health care policies and responses to ACA Supreme Court scenarios, and the environment for health care businesses and dealmaking.
Panelists:
Mike King, shareholder at Brownstein Hyatt Farber Schreck
Nadeam Elshami, policy director at Brownstein Hyatt Farber Schreck
Brian McGuire, policy director at Brownstein Hyatt Farber Schreck
Dr. Elizabeth Hawk, faculty at Stanford School of Medicine and president at Ampersand Intelligence
Recent Insights
Read MorePresident Trump Sends Letters Updating Tariffs; Extends “Reciprocal” Tariff Pause to Aug. 1
Client Alert | July 07, 2025The First Amendment and Direct-to-Consumer (DTC) Prescription Drug Ads
Client Alert | July 03, 2025White House Seeks To Streamline Funding For Domestic Energy, Critical Mineral Projects
Client Alert | July 02, 2025Senate Finance Committee Tax Title – Summary and Analysis
Client Alert | July 01, 2025Senate Health, Education, Labor and Pensions Committee Reconciliation Bill Summary
Client Alert | July 01, 2025Senate Concludes OBBBA Vote-a-Rama
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.